Pharmaceuticals firm thinks creating cluster of companies at its site could result in up to 5,000 jobs
GlaxoSmithKline is seeking to create a £400m campus in Stevenage for new life sciences companies that it believes could result in up to 5,000 jobs over the next decade.
The pharmaceuticals company has kicked off a process to find a private sector developer to transform a third of its existing 37-hectare (92 acres) research and development site in Stevenage into one of Europe’s largest clusters for new life sciences businesses.
